Target intelligence / Profile preview

Mutan (alpha-1,3-glucan)

Molecular classification
Polysaccharide, Extracellular matrix component
01

Overview

Mutan is a water-insoluble polysaccharide primarily composed of alpha-1,3-linked glucose residues, synthesized by Streptococcus mutans and other oral streptococci via glucosyltransferase (Gtf) enzymes [2, 5]. It serves as a fundamental structural component of the extracellular polymeric substance (EPS) matrix in dental plaque, facilitating the stable adherence of cariogenic bacteria to tooth surfaces and mediating inter-bacterial aggregation [8, 11]. By providing a protective and cohesive scaffold, mutan promotes the development of biofilms that trap organic acids produced during sugar fermentation, which eventually leads to the demineralization of tooth enamel and the formation of dental caries [3, 9]. Beyond its structural role, mutan has been shown to induce inflammatory responses by stimulating osteoclast differentiation, potentially contributing to alveolar bone loss in periodontal disease [21]. In therapeutic contexts, mutan is considered a key target for anti-biofilm strategies, where enzymes such as mutanase (alpha-1,3-glucanase) are utilized to hydrolyze its glycosidic bonds, thereby destabilizing the plaque matrix and enhancing the efficacy of mechanical cleaning and antimicrobial agents [7, 14].

Other names
alpha-1,3-linked glucanWater-insoluble glucanInsoluble streptococcal glucanMutan polysaccharide
02

Mechanism of action

Enzymatic hydrolysis of alpha-1,3-glycosidic linkages to degrade the dental biofilm matrix, or inhibition of its synthesis to prevent bacterial colonization [9, 14].

03

Biological functions

Biofilm formationBacterial adhesionExtracellular matrix structural supportPro-inflammatory signaling
04

Disease associations

Dental caries (tooth decay) [3]Periodontal disease [21]Alveolar bone loss [21]
05

Safety considerations

Disruption of the commensal oral microbiome [11]Potential for hypersensitivity or allergic reactions to exogenous microbial-derived enzymes [12]
06

Interacting drugs

Mutanase (alpha-1,3-glucanase) [7]

2 more in the full profile.

07

Biomarkers

Dental plaque index [11]Streptococcus mutans colony-forming units (CFU) [10]Salivary glucan levels [21]

Beyond the preview

Go deeper on Mutan (alpha-1,3-glucan).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mutan (alpha-1,3-glucan).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call